Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)

Clinical trial NCT01076192 · COMPLETED

Trial details

NCT number: NCT01076192
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Study type: OBSERVATIONAL

Moderate-to-severe Chronic Plaque Psoriasis

Start date: 2010-02-01
Primary completion: 2014-09-01
Enrollment: 547

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.